The AMStent^® Tracheobronchial Covered Stent System is indicated for treatment of tracheobronchial strictures produced by malignant neoplasms in adult patients.

AMStent^® is a U.S. registered trademark, and Peytant^™ and Zymeric^™ are U.S. trademarks of Peytant Solutions, Inc.